Sarepta Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sarepta Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $0.62 | $0.37 | 67.6 % |
Jun 2024 | 2024-08-07 | $0.44 | $0.02 | 2100.0 % |
Mar 2024 | 2024-05-01 | $0.73 | $-0.07 | 1142.9 % |
Dec 2023 | 2024-02-28 | $0.82 | $0.01 | 8100.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $467.17M | $409.30M | 14.1 % |
Jun 2024 | 2024-08-07 | $362.93M | $396.26M | -8.41 % |
Mar 2024 | 2024-05-01 | $413.46M | $373.28M | 10.8 % |
Dec 2023 | 2024-02-28 | $396.78M | $385.81M | 2.84 % |
Sarepta Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
Sarepta Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $0.62, which beat the estimate of $0.37.
Sarepta Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.